| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2022 | BOSTON CELL STANDARDS INC. | 35 CHERYL DR | SHARON | MA | 02067-1118 | NORFOLK | USA | R44CA268484 | National Immunohistochemistry Standardization Program - Establishment & Launch | 000 | 2 | NIH | 2/3/2025 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $898,163 ) |
| | 2022 | 2022 | BOSTON CELL STANDARDS INC | 35 CHERYL DR | SHARON | MA | 02067-1118 | NORFOLK | USA | R44CA268484 | National Immunohistochemistry Standardization Program - Establishment & Launch | 000 | 2 | NIH | 8/5/2022 | $898,163 |
|
| Issue Date FY: 2021 ( Subtotal = $1,101,356 ) |
| | 2021 | 2021 | BOSTON CELL STANDARDS INC | 35 CHERYL DR | SHARON | MA | 02067-1118 | NORFOLK | USA | R44CA268484 | National Immunohistochemistry Standardization Program - Establishment & Launch | 000 | 1 | NIH | 9/21/2021 | $1,101,356 |
|
| Issue Date FY: 2020 ( Subtotal = $0 ) |
| | 2020 | 2018 | BOSTON CELL STANDARDS LLC | 35 CHERYL DR | SHARON | MA | 02067-1118 | NORFOLK | USA | R44CA213476 | Regulatory Validation of Standardized Clinical Laboratory Immunohistochemistry Controls | 001 | 2 | NIH | 5/13/2020 | $0 |
| | 2020 | 2018 | BOSTON CELL STANDARDS LLC | 35 CHERYL DR | SHARON | MA | 02067-1118 | NORFOLK | USA | R44CA213476 | Regulatory Validation of Standardized Clinical Laboratory Immunohistochemistry Controls | 000 | 2 | NIH | 3/19/2020 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $751,890 ) |
| | 2018 | 2018 | MEDICAL DISCOVERY PARTNERS LLC | 35 CHERYL DR | SHARON | MA | 02067-1118 | NORFOLK | USA | R44CA213476 | Regulatory Validation of Standardized Clinical Laboratory Immunohistochemistry Controls | 000 | 2 | NIH | 4/12/2018 | $749,890 |
| | 2018 | 2018 | MEDICAL DISCOVERY PARTNERS LLC | 35 CHERYL DR | SHARON | MA | 02067-1118 | NORFOLK | USA | R44CA213476 | Regulatory Validation of Standardized Clinical Laboratory Immunohistochemistry Controls | 001 | 2 | NIH | 8/3/2018 | $2,000 |
|
| Issue Date FY: 2017 ( Subtotal = $749,890 ) |
| | 2017 | 2017 | MEDICAL DISCOVERY PARTNERS LLC | 35 CHERYL DR | SHARON | MA | 02067-1118 | NORFOLK | USA | R44CA213476 | Regulatory Validation of Standardized Clinical Laboratory Immunohistochemistry Controls | 000 | 1 | NIH | 1/4/2017 | $749,890 |
| | 2017 | 2016 | MEDICAL DISCOVERY PARTNERS LLC | 35 CHERYL DR | SHARON | MA | 02067-1118 | NORFOLK | USA | R44CA183203 | Regulatory Validation of Standardized Clinical Immunohistochemistry Controls | 000 | 3 | NIH | 8/17/2017 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $477,976 ) |
| | 2016 | 2016 | MEDICAL DISCOVERY PARTNERS LLC | 35 CHERYL DRIVE | SHARON | MA | 02067-1118 | NORFOLK | USA | R44CA183203 | Regulatory Validation of Standardized Clinical Immunohistochemistry Controls | 000 | 3 | NIH | 4/19/2016 | $477,976 |
|
| Issue Date FY: 2015 ( Subtotal = $679,166 ) |
| | 2015 | 2015 | MEDICAL DISCOVERY PARTNERS LLC | 35 CHERYL DRIVE | SHARON | MA | 02067-1118 | NORFOLK | USA | R44CA183203 | Regulatory Validation of Standardized Clinical Immunohistochemistry Controls | 000 | 2 | NIH | 4/27/2015 | $679,166 |
|
| Issue Date FY: 2014 ( Subtotal = $219,202 ) |
| | 2014 | 2014 | MEDICAL DISCOVERY PARTNERS LLC | 35 CHERYL DRIVE | SHARON | MA | 02067-1118 | NORFOLK | USA | R44CA183203 | Regulatory Validation of Standardized Clinical Immunohistochemistry Controls | 000 | 1 | NIH | 5/21/2014 | $219,202 |
|
| Issue Date FY: 2011 ( Subtotal = $301,893 ) |
| | 2011 | 2011 | MEDICAL DISCOVERY PARTNERS LLC | 35 CHERYL DRIVE | SHARON | MA | 02067-1118 | NORFOLK | USA | R43AI092886 | IDENTIFICATION OF SEROLOGIC BIOMARKERS IN SARCOIDOSIS | 000 | 1 | NIH | 4/14/2011 | $301,893 |
|
| Issue Date FY: 2009 ( Subtotal = $0 ) |
| | 2009 | 2008 | MEDICAL DISCOVERY PARTNERS LLC | 35 CHERYL DRIVE | SHARON | MA | 02067 | NORFOLK | USA | R43HL093903 | IDENTIFICATION OF THERAPEUTIC PEPTIDES FOR ASTHMA | 000 | 1 | NIH | 11/10/2008 | $0 |
|
| Issue Date FY: 2008 ( Subtotal = $373,948 ) |
| | 2008 | 2008 | MEDICAL DISCOVERY PARTNERS LLC | 35 CHERYL DRIVE | SHARON | MA | 02067 | NORFOLK | USA | R43HL093903 | IDENTIFICATION OF THERAPEUTIC PEPTIDES FOR ASTHMA | 000 | 1 | NIH | 9/15/2008 | $228,220 |
| | 2008 | 2008 | MEDICAL DISCOVERY PARTNERS LLC | 35 CHERYL DRIVE | SHARON | MA | 02067 | NORFOLK | USA | R43CA132467 | PARAPROTEIN-SPECIFIC DETECTION & QUANTIFICATION IN CLINICAL GAMMOPATHIES | 000 | 1 | NIH | 6/30/2008 | $145,728 |
|
| Issue Date FY: 2007 ( Subtotal = $678,478 ) |
| | 2007 | 2007 | MEDICAL DISCOVERY PARTNERS LLC | 35 CHERYL DRIVE | SHARON | MA | 02067 | NORFOLK | USA | R44CA106847 | CLINICAL VALIDATION OF ER/PR TEST CONTROLS & CALIBRATORS | 000 | 3 | NIH | 3/2/2007 | $578,478 |
| | 2007 | 2007 | MEDICAL DISCOVERY PARTNERS LLC | 35 CHERYL DRIVE | SHARON | MA | 02067 | NORFOLK | USA | R43CA125605 | ISOLATION OF CIRCULATING TUMOR CELLS FROM PERIPHERAL BLOOD | 000 | 1 | NIH | 4/17/2007 | $100,000 |
|
| Issue Date FY: 2006 ( Subtotal = $545,666 ) |
| | 2006 | 2006 | MEDICAL DISCOVERY PARTNERS LLC | 35 CHERYL DRIVE | SHARON | MA | 02067 | NORFOLK | USA | R44CA106847 | CLINICAL VALIDATION OF ER/PR TEST CONTROLS & CALIBRATORS | 000 | 2 | NIH | 3/6/2006 | $545,666 |
|
| Issue Date FY: 2005 ( Subtotal = $428,422 ) |
| | 2005 | 2005 | MEDICAL DISCOVERY PARTNERS LLC | 35 CHERYL DRIVE | SHARON | MA | 02067 | NORFOLK | USA | R44CA094557 | SYNTHETIC CALIBRATORS FOR IMMUNOHISTOCHEMICAL ASSAYS | 000 | 4 | NIH | 4/6/2005 | $428,422 |
|
| Issue Date FY: 2004 ( Subtotal = $660,346 ) |
| | 2004 | 2004 | MEDICAL DISCOVERY PARTNERS LLC | 35 CHERYL DRIVE | SHARON | MA | 02067 | NORFOLK | USA | R44CA094557 | SYNTHETIC CALIBRATORS FOR IMMUNOHISTOCHEMICAL ASSAYS | 000 | 3 | NIH | 7/26/2004 | $435,002 |
| | 2004 | 2004 | MEDICAL DISCOVERY PARTNERS LLC | 35 CHERYL DRIVE | SHARON | MA | 02067 | NORFOLK | USA | R44CA106847 | CLINICAL VALIDATION OF ER/PR TEST CONTROLS & CALIBRATORS | 000 | 1 | NIH | 6/1/2004 | $225,344 |
|
|
